Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Kane

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|November 18, 2015
Infectious basophilia?John P Kane
Diabetes Technology & Therapeutics|June 25, 2002
Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?John P Kane
Journal of the American College of Cardiology|June 18, 2013
New horizons in lipid managementJohn P Kane
Current Opinion in Lipidology|January 19, 2016
Emerging molecular strategies for management of dyslipidemiasJohn P Kane, Mary J Malloy
Journal of Lipid Research|June 9, 2012
New molecular insights into CETP structure and function: a reviewM Arthur Charles, John P Kane
Current Opinion in Lipidology|September 6, 2013
Needed: a better understanding of the antiatherogenic properties of HDLJohn P Kane, Mary J Malloy
Current Opinion in Lipidology|November 20, 2012
Hyperlipidemia and cardiovascular diseaseMary J Malloy, John P Kane
Circulation Research|June 14, 2003
Apolipoprotein A-II: active or passive role in familial combined hyperlipidemiaBradley E Aouizerat, John P Kane
Current Opinion in Lipidology|April 21, 2012
Prebeta-1 HDL and coronary heart diseaseJohn P Kane, Mary J Malloy
Current Opinion in Lipidology|November 3, 2016
Lipoproteins and amyloid vascular diseaseJohn P Kane, Mary J Malloy
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|November 18, 2015
Infectious basophilia?John P Kane
Diabetes Technology & Therapeutics|June 25, 2002
Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?John P Kane
Journal of the American College of Cardiology|June 18, 2013
New horizons in lipid managementJohn P Kane
Current Opinion in Lipidology|January 19, 2016
Emerging molecular strategies for management of dyslipidemiasJohn P Kane, Mary J Malloy
Journal of Lipid Research|June 9, 2012
New molecular insights into CETP structure and function: a reviewM Arthur Charles, John P Kane
Current Opinion in Lipidology|September 6, 2013
Needed: a better understanding of the antiatherogenic properties of HDLJohn P Kane, Mary J Malloy
Current Opinion in Lipidology|November 20, 2012
Hyperlipidemia and cardiovascular diseaseMary J Malloy, John P Kane
Circulation Research|June 14, 2003
Apolipoprotein A-II: active or passive role in familial combined hyperlipidemiaBradley E Aouizerat, John P Kane
Current Opinion in Lipidology|April 21, 2012
Prebeta-1 HDL and coronary heart diseaseJohn P Kane, Mary J Malloy
Current Opinion in Lipidology|November 3, 2016
Lipoproteins and amyloid vascular diseaseJohn P Kane, Mary J Malloy
Pageof 12